Boardroom Alpha
Research library
SPACs · Oct 28, 2026

SPAC Market Update October 28, 2026: CCXI-Agility $300M Order, JACS Extension Vote Set

Churchill Capital Corp XI (CCXI) published an Agility transcript on October 28, 2026, citing a $300 million Digit 5 order subject to milestones ahead of the proposed combination. Separately, Jackson Acquisition Co Ii (JACS) set November 20, 2026 for an…

SPAC IPO Update — October 28, 2026

No SPAC IPOs priced on October 28, 2026; October MTD now stands at 5 IPOs totaling $591M over 28 sessions.

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 5•Prior: 5•MoM: 0
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
16
Apr ’26
20
May ’26
19
Jun ’26
18
Jul ’26
12
Aug ’26
5
Sep ’26
5
Oct ’26
Source: Boardroom Alpha
IPO Activity SnapshotMonth-to-date: 5 IPOs ($591M) vs. first 28 days of last month 5 ($940M) · 12-mo avg: 16/mo
$ totals include underwriter over-allotment.
New SPAC IPOs
Date Ticker Issuer IPO Size Trust Funding
Oct 27 SCQC SPACCircle Acquisition Corp. $100M 100.5%
Source: Boardroom Alpha

Daily SPAC Update — October 28, 2026

SPAC DEAL & EXTENSION VOTES SET
Jackson Acquisition Co II (JACS) * EXTENSION VOTE SET: November 20, 2026 * trust $10.86

EXTENSION VOTES
NEWBURY STREET II ACQUISITION CORP (NTWO)vote October 28, 2026 -> extend from November 4, 2026 to February 4, 2027

OTHER SPAC NEWS
BOLD EAGLE ACQUISITION CORP (BEAG) * Trust Update * trust $10.73
CHURCHILL CAPITAL CORP XI (CCXI) * Media TranscriptAgility reported expanded GXO deployments, a $300 million Digit 5 order subject to milestones, and 2027 customer and commercial targets ahead of its proposed Churchill XI combination.
K&F GROWTH ACQUISITION CORP II (KFII) * Media TranscriptDavid’s Bridal plans to spin off Pearl as a public company through a proposed SPAC combination, with CEO Kelly Cook leading the new entity.

SPAC DEALS ANNOUNCED
October 26 | Amanat Acquisition Corp (AMAN) + Corxel PharmaceuticalsCorxel Pharmaceuticals is a clinical-stage biopharmaceutical company that develops oral medicines for obesity and related cardiometabolic conditions. Its lead product candidate, CX11, is a once-daily oral GLP-1 receptor agonist that has completed Phase 2 clinical development in the United States and Phase 3 clinical development in Asia. The company is also advancing CX12, an investigational oral amylin receptor agonist currently in preclinical development.

SPAC Movers — October 28, 2026

YESTERDAY’S TOP SPAC GAINERS
Company Ticker Change Price Stage
RF ACQUISITION CORP II RFAI 37.0% $ 35.83 Announced
RIBBON ACQUISITION CORP RIBB 18.3% $ 6.71 Announced
FUTURE VISION II ACQUISITION CORP FVN 5.4% $ 11.75 Announced
QUETTA ACQUISITION CORP QETA 3.1% $ 11.55 Announced
RISING DRAGON ACQUISITION CORP RDAC 2.7% $ 5.03 Announced
YESTERDAY’S TOP SPAC LOSERS
Company Ticker Change Price Stage
CALISA ACQUISITION CORP ALIS -8.5% $ 8.20 Announced
MELAR ACQUISITION CORP I MACI -7.1% $ 10.22 Announced
TCGX ACQUISITION CORP II TCXB -2.1% $ 10.27 Pre-Deal
AI INFRASTRUCTURE ACQUISITION CORP AIIA -1.3% $ 10.22 Pre-Deal
BOLD EAGLE ACQUISITION CORP BEAG -1.2% $ 10.39 Announced
Source: Boardroom Alpha market data

Frequently Asked Questions

  • What did Churchill Capital Corp XI disclose about Agility?
    Churchill Capital Corp XI (CCXI) published an Agility transcript citing expanded GXO deployments, a $300 million Digit 5 order subject to milestones, and 2027 customer and commercial targets ahead of the proposed combination.
  • When is the JACS extension vote scheduled?
    Jackson Acquisition Co II (JACS) set November 20, 2026 for an extension vote. The SPAC’s trust was listed at $10.86 in the activity feed.
  • What did Newbury Street II Acquisition Corp vote on today?
    Newbury Street II Acquisition Corp (NTWO) held an October 28, 2026 extension vote covering a deadline move from November 4, 2026 to February 4, 2027.
  • How many SPAC IPOs priced in October 2026 through October 28?
    5 SPAC IPOs priced for $591M through the first 28 days of October 2026, compared with 5 IPOs for $940M over the same span in September 2026.


Get it in your inbox

The Daily SPAC Update in your inbox

Every IPO, vote, and DeSPAC close — analyzed daily for finance professionals.

ShareXLinkedIn

Published Oct 28, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer